Evaluation of the effectiveness of crenothempy in treating generalized anxiety disorder;Évaluation de l'efficacité du thermalisme à orientation psychosomatique

Sante Publique

Volumn 20, Issue 2, 2008, Pages 105-112

  Salamon, Roger ^a   Germain, Christine ^b   Olié, Jean Pierre ^a   Dubois, Olivier ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Clinique de Saujon   (France)

Author keywords

Crenotherapy; General anxiety disorder; Randomized clinical trial

Indexed keywords

ANTIDEPRESSANT AGENT; PAROXETINE;

ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; RANDOMIZED CONTROLLED TRIAL;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY DISORDERS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; PAROXETINE;

EID: 53049089073     PISSN: 09953914     EISSN: None     Source Type: Journal    
DOI: 10.3917/spub.082.0105     Document Type: Article

References (14)

1. American Psychiatric Association. DSM-IV -TR Manuel diagnostique et statistique des troubles mentaux. Texte révisé. Troubles anxieux. 4e édition. Washington: APA, 2000. Traduction française Guelfi JD. Paris: Masson, 2003:493-560.
2. Belin J, Montastruc JL, Montastruc P. Drug prescription and Drug Monitoring in Crénothérapy. Therapie 1990;45:51-2.
3. Boyer P. Le Quotidien du Médecin 2003;(7302)
4. Bruss GS, Gruenberg AM, Goldstein RD, Barber JP. Hamilton Anxiety Rating Scale Interview guide: joint interview and test-retest methods for interrater reliability. Psychiatry Res 1994;53(2):191-202.
5. Dubois O, Boulange M, Loo H. Thermalisme, Hydrothérapie et Psychiatrie. Paris: Masson, 2000.
6. Dutkiewicz R, Llau Bousquet Melou ME, Lapeyre Mestre M, Montastruc JL. Effets indésirables des cures thermales : à propos d'une étude prospective systématique à Bagnères de Bigorre. Presse Therm Clim 1999;(1):9-13.
7. Ferreri M. Le Quotidien du Médecin 2003 (7266).
8. Guillard AR. Syndromes dépressifs et traitement par la cure thermale de Néris-les-Bains. Rev Psychol Med 1990;22:549-60.
9. Kessler RC, McGonagle KA, Zhao S, et al. Left Time and Twelve Month Prevalence of DSM III R Psychiatric Disorders in the United-States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
10. M.I.N.I. 5.0.0 / French version / DSM-IV / lifetime (November 1998).
11. Pollack MH, Zaninelli R, Goddard A, et al. Paroxetine in the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled, Flexible-Dosage Trial. J Clin Psychiatry 2001;62:350-7.
12. Rickels K, Zaninelli R, McCafferty I, Bellew K, Iyengar M, Sheehan D. Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study. Am J Psychiatry 2003;160:749-56.
13. Vidart L, Bernier M, Laurenceau D. Note statistique sur 300 cas d'insomnie traitée en milieu thermal. Ann. Medico Psychol 1977;135:812-21.
14. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:355-64.